Brown & Brown vs The Baldwin Insurance Group: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Brown & Brown Inc (BRO)

Q3 202623 Jul – 9 Oct 2026

▲3

AI push and deal-driven growth offset weak organic revenue

AI-first overhaul with Anthropic, McKinsey, Accenture Brown & Brown is rolling out AI across all 23,000 staff with outside partners, targeting faster workflows and up to 2x-8x productivity gains in early tests. If it works, it should lift profit margins over the next few years, which supports the stock price.
This is the main new strategic driver of future earnings and the biggest positive force in the period.
Q2 revenue beat on growth but organic sales slipped Second-quarter revenue rose 30.4% to about $1.7 billion, mostly from acquisitions, but organic revenue fell 0.7% and missed analyst estimates. Adjusted profit matched expectations. The weak underlying growth is a real counterweight to the headline growth story.
It shows the core business is not growing on its own, which tempers the positive acquisition-driven numbers.
Cost savings and buybacks support per-share value Management expects $30-40 million of cost savings this year from recent deals, and the company bought back $250 million of stock while raising its dividend 10%. Fewer shares and lower costs help per-share earnings even when revenue growth is uneven.
These capital actions directly support the stock price and are new details from the quarter.
Canada expansion of Marcus & Millichap partnership Brown & Brown's preferred partner program with Marcus & Millichap expanded into Canada, giving its commercial real estate clients access to Brown & Brown's insurance and risk services. This opens a new source of customer demand outside the U.S.
It is a fresh demand-side growth avenue that could add revenue over time.

August 202623 Jul – 9 Oct 2026

▲3

AI push and deal-driven growth offset weak organic revenue

AI-first overhaul with Anthropic, McKinsey, Accenture Brown & Brown is rolling out AI across all 23,000 staff with outside partners, targeting faster workflows and up to 2x-8x productivity gains in early tests. If it works, it should lift profit margins over the next few years, which supports the stock price.
This is the main new strategic driver of future earnings and the biggest positive force in the period.
Q2 revenue beat on growth but organic sales slipped Second-quarter revenue rose 30.4% to about $1.7 billion, mostly from acquisitions, but organic revenue fell 0.7% and missed analyst estimates. Adjusted profit matched expectations. The weak underlying growth is a real counterweight to the headline growth story.
It shows the core business is not growing on its own, which tempers the positive acquisition-driven numbers.
Cost savings and buybacks support per-share value Management expects $30-40 million of cost savings this year from recent deals, and the company bought back $250 million of stock while raising its dividend 10%. Fewer shares and lower costs help per-share earnings even when revenue growth is uneven.
These capital actions directly support the stock price and are new details from the quarter.
Canada expansion of Marcus & Millichap partnership Brown & Brown's preferred partner program with Marcus & Millichap expanded into Canada, giving its commercial real estate clients access to Brown & Brown's insurance and risk services. This opens a new source of customer demand outside the U.S.
It is a fresh demand-side growth avenue that could add revenue over time.

Latest23 Jul – 9 Oct 2026

▲3

AI push and deal-driven growth offset weak organic revenue

AI-first overhaul with Anthropic, McKinsey, Accenture Brown & Brown is rolling out AI across all 23,000 staff with outside partners, targeting faster workflows and up to 2x-8x productivity gains in early tests. If it works, it should lift profit margins over the next few years, which supports the stock price.
This is the main new strategic driver of future earnings and the biggest positive force in the period.
Q2 revenue beat on growth but organic sales slipped Second-quarter revenue rose 30.4% to about $1.7 billion, mostly from acquisitions, but organic revenue fell 0.7% and missed analyst estimates. Adjusted profit matched expectations. The weak underlying growth is a real counterweight to the headline growth story.
It shows the core business is not growing on its own, which tempers the positive acquisition-driven numbers.
Cost savings and buybacks support per-share value Management expects $30-40 million of cost savings this year from recent deals, and the company bought back $250 million of stock while raising its dividend 10%. Fewer shares and lower costs help per-share earnings even when revenue growth is uneven.
These capital actions directly support the stock price and are new details from the quarter.
Canada expansion of Marcus & Millichap partnership Brown & Brown's preferred partner program with Marcus & Millichap expanded into Canada, giving its commercial real estate clients access to Brown & Brown's insurance and risk services. This opens a new source of customer demand outside the U.S.
It is a fresh demand-side growth avenue that could add revenue over time.

The Baldwin Insurance Group, Inc. (BWIN)

Q3 202631 Jul – 28 Sep 2026

▲2

Baldwin to go private in $7.7B cash deal at $32.50 a share

Take-private at a big cash premium Sequence Holdings and Michael Dell's family office agreed to buy Baldwin for $7.7 billion, paying $32.50 a share in cash — about an 88% premium to the price before deal talks surfaced. That fixed cash price is why the stock jumped and now trades near $32, close to the offer.
The take-private is the single event that now sets BWIN's price.
Buyers committed, no financing condition The buyers signed a definitive deal with no financing condition, and the board unanimously approved it. Eligible employees can roll part of their stock into the private company. That structure makes the $32.50 payout look more certain, supporting the shares near the offer price.
Deal certainty is what keeps the stock pinned near the cash offer.
Little upside left; closing still needs approvals With shares around $31.89 versus the $32.50 cash offer, almost all the gain is already priced in. Shareholders must still vote and regulators must clear the deal, expected to close in early 2027, so any delay or rejection is the main risk now.
It is the real counterweight: the easy money has been made and completion risk remains.
Solid profit growth, but weak organic sales and a net loss Baldwin entered the deal with revenue up 30% and adjusted EBITDA up 37%, yet organic revenue rose only 2% and it posted a $56 million GAAP net loss. The buyers are paying about 20 times trailing adjusted EBITDA, a full price that reflects these mixed results.
It explains the operating backdrop behind the price the buyers agreed to pay.

August 202631 Jul – 28 Sep 2026

▲2

Baldwin to go private in $7.7B cash deal at $32.50 a share

Take-private at a big cash premium Sequence Holdings and Michael Dell's family office agreed to buy Baldwin for $7.7 billion, paying $32.50 a share in cash — about an 88% premium to the price before deal talks surfaced. That fixed cash price is why the stock jumped and now trades near $32, close to the offer.
The take-private is the single event that now sets BWIN's price.
Buyers committed, no financing condition The buyers signed a definitive deal with no financing condition, and the board unanimously approved it. Eligible employees can roll part of their stock into the private company. That structure makes the $32.50 payout look more certain, supporting the shares near the offer price.
Deal certainty is what keeps the stock pinned near the cash offer.
Little upside left; closing still needs approvals With shares around $31.89 versus the $32.50 cash offer, almost all the gain is already priced in. Shareholders must still vote and regulators must clear the deal, expected to close in early 2027, so any delay or rejection is the main risk now.
It is the real counterweight: the easy money has been made and completion risk remains.
Solid profit growth, but weak organic sales and a net loss Baldwin entered the deal with revenue up 30% and adjusted EBITDA up 37%, yet organic revenue rose only 2% and it posted a $56 million GAAP net loss. The buyers are paying about 20 times trailing adjusted EBITDA, a full price that reflects these mixed results.
It explains the operating backdrop behind the price the buyers agreed to pay.

Latest31 Jul – 28 Sep 2026

▲2

Baldwin to go private in $7.7B cash deal at $32.50 a share

Take-private at a big cash premium Sequence Holdings and Michael Dell's family office agreed to buy Baldwin for $7.7 billion, paying $32.50 a share in cash — about an 88% premium to the price before deal talks surfaced. That fixed cash price is why the stock jumped and now trades near $32, close to the offer.
The take-private is the single event that now sets BWIN's price.
Buyers committed, no financing condition The buyers signed a definitive deal with no financing condition, and the board unanimously approved it. Eligible employees can roll part of their stock into the private company. That structure makes the $32.50 payout look more certain, supporting the shares near the offer price.
Deal certainty is what keeps the stock pinned near the cash offer.
Little upside left; closing still needs approvals With shares around $31.89 versus the $32.50 cash offer, almost all the gain is already priced in. Shareholders must still vote and regulators must clear the deal, expected to close in early 2027, so any delay or rejection is the main risk now.
It is the real counterweight: the easy money has been made and completion risk remains.
Solid profit growth, but weak organic sales and a net loss Baldwin entered the deal with revenue up 30% and adjusted EBITDA up 37%, yet organic revenue rose only 2% and it posted a $56 million GAAP net loss. The buyers are paying about 20 times trailing adjusted EBITDA, a full price that reflects these mixed results.
It explains the operating backdrop behind the price the buyers agreed to pay.